PLA2G2A and cancer: Different types of sPLA2s and synthetic peptides derived from sPLA2 homologues have been shown to possess antitumor and antiangiogenic activity against different cancer cells in vitro. The antitumor activities have been detected for the acidic BthA-I-PLA2 from Bothrops jararacussu venom [40], for RVV-7, a basic 7 kDa toxin from Russell’s viper venom [41], for two sPLA2s from Cerastes cerastes venom [42], for sPLA2 from Naja naja atra venom [43], for a Lys49 sPLA2 from Protobothrops flavoviridis venom [44], for a Drs-PLA2 from Daboia russelii siamensis venom [45].